Neurogene Inc. Property, Plant and Equipment, Gross
Neurogene Inc. (NGNE) had Property, Plant and Equipment, Gross of $27.50 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-11
- 2026-06-30: Property, Plant and Equipment, Gross $27.50M.
- 2026-03-31: Property, Plant and Equipment, Gross $27.46M.
- 2025-12-31: Property, Plant and Equipment, Gross $26.90M.
- 2025-09-30: Property, Plant and Equipment, Gross $26.91M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $27.50M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $27.46M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $26.90M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $26.91M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $26.91M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $26.73M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $26.59M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $26.45M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $25.66M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $25.27M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $25.18M 10-K · filed 2025-03-24 | |
| 2022-12-31 | $24.88M 10-K · filed 2024-03-18 | |
| 2020-12-31 | $4.16M 10-K · filed 2021-03-25 | |
| 2019-12-31 | $2.75M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $843.00K 10-K · filed 2020-03-12 | |
| 2017-12-31 | $1.44M 10-K · filed 2019-03-07 | |
| 2016-12-31 | $1.02M 10-K · filed 2018-03-12 | |
| 2015-12-31 | $179.00K 10-K · filed 2017-03-09 | |
| 2014-12-31 | $382.00K 10-K · filed 2016-03-14 | $382.56K 10-K · filed 2015-03-16 |
| 2013-12-31 | $328.19K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |